Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Discovery of furopyridine-based compounds as novel inhibitors of Janus kinase 2: In silico and in vitro studies.
Int J Biol Macromol. 2024 Mar;260(Pt 2):129308. doi: 10.1016/j.ijbiomac.2024.129308. Epub 2024 Jan 11.
Int J Biol Macromol. 2024.
PMID: 38218283
Discovery of Novel EGFR Inhibitor Targeting Wild-Type and Mutant Forms of EGFR: In Silico and In Vitro Study.
Todsaporn D, Zubenko A, Kartsev V, Aiebchun T, Mahalapbutr P, Petrou A, Geronikaki A, Divaeva L, Chekrisheva V, Yildiz I, Choowongkomon K, Rungrotmongkol T.
Todsaporn D, et al. Among authors: divaeva l.
Molecules. 2023 Mar 28;28(7):3014. doi: 10.3390/molecules28073014.
Molecules. 2023.
PMID: 37049777
Free PMC article.
Item in Clipboard
Tautomeric and non-tautomeric N-substituted 2-iminobenzimidazolines as new lead compounds for the design of anti-influenza drugs: An in vitro study.
Zarubaev VV, Morkovnik AS, Divaeva LN, Karpinskaya LA, Borodkin GS.
Zarubaev VV, et al. Among authors: divaeva ln.
Bioorg Med Chem. 2016 Nov 15;24(22):5796-5803. doi: 10.1016/j.bmc.2016.09.036. Epub 2016 Sep 15.
Bioorg Med Chem. 2016.
PMID: 27670100
Item in Clipboard
Cite
Cite